首页> 外文期刊>Kidney >Pulmonary Hypertension in Renal Failure Patients
【24h】

Pulmonary Hypertension in Renal Failure Patients

机译:肾衰竭患者的肺动脉高压

获取原文
获取原文并翻译 | 示例
       

摘要

Patients with end-stage renal disease (ESRD) continue to have a higher morbidity and mortality despite the advances in renal replacement therapy. Cardiovascular events are the main causes of increased morbidity and mortality. Recent reports have demonstrated a high incidence of unexplained pulmonary hypertension in patients with ESRD on replacement therapy and at the predialysis stage. This serious cardiovascular complication is associated with increased mortality in this group of patients. Highlighting this problem is important for prevention, enabling early detection, and proper management. Understanding the pathophysiology of the disease is important for its management. In this review, we tried to collect most of the available data about this category of pulmonary hypertension in patients with ESRD.
机译:尽管肾脏替代疗法取得了进步,但终末期肾脏病(ESRD)患者的发病率和死亡率仍较高。心血管事件是发病率和死亡率增加的主要原因。最近的报道表明,在替代疗法和透析前阶段,ESRD患者发生无法解释的肺动脉高压的发生率很高。这种严重的心血管并发症与该组患者的死亡率增加有关。突出此问题对于预防,实现早期发现和适当管理非常重要。了解该疾病的病理生理学对其管理很重要。在这篇综述中,我们试图收集有关ESRD患者这类肺动脉高压的大多数可用数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号